Natural HDAC Inhibitors for Epigenetic Combating of Cancer Progression (Hardcover)


General compendium of HDAC inhibitors with deep emphasis on toxicity issues of synthetic HDAC inhibitors Various groups of natural HDAC inhibitors, their representatives and premier sources Cyclic tetrapeptides of natural origin and their importance as cancer chemotherapeutic agents Hydroxamates and depsipeptides from natural sources and their promising role in cancer therapy Natural Flavonoids, their HDAC inhibitory tendency and marvellous anticancer activity Non-flavonoid natural HDAC inhibitors and their pleasing cytotoxic effects towards cancer models Combined therapy involving natural flavonoids with other anticancer molecules for synergistic and additive benefits against cancer models Non-flavonoid HDAC inhibitors and conventional drugs in collaborative mode against aggressive malignancies Nanotechnology based delivery of natural HDAC inhibitors for greater therapeutic efficacy over traditional combinatorial therapy

R2,780

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles27800
Mobicred@R261pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 9 - 15 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

General compendium of HDAC inhibitors with deep emphasis on toxicity issues of synthetic HDAC inhibitors Various groups of natural HDAC inhibitors, their representatives and premier sources Cyclic tetrapeptides of natural origin and their importance as cancer chemotherapeutic agents Hydroxamates and depsipeptides from natural sources and their promising role in cancer therapy Natural Flavonoids, their HDAC inhibitory tendency and marvellous anticancer activity Non-flavonoid natural HDAC inhibitors and their pleasing cytotoxic effects towards cancer models Combined therapy involving natural flavonoids with other anticancer molecules for synergistic and additive benefits against cancer models Non-flavonoid HDAC inhibitors and conventional drugs in collaborative mode against aggressive malignancies Nanotechnology based delivery of natural HDAC inhibitors for greater therapeutic efficacy over traditional combinatorial therapy

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Taylor & Francis

Country of origin

United Kingdom

Release date

March 2023

Availability

Expected to ship within 9 - 15 working days

First published

2023

Authors

Dimensions

234 x 156mm (L x W)

Format

Hardcover

Pages

154

ISBN-13

978-1-03-227986-2

Barcode

9781032279862

Categories

LSN

1-03-227986-9



Trending On Loot